AIM
SURF

ARK Investment Management’s Surface Oncology, Inc. Common Stock SURF Stock Holding History

ARK Investment Management’s Portfolio SURF Stock Details SURF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,412,077
Closed -$1.23M – 232
2023
Q2 		$1.23M Sell
1,412,077
-4,084,069
-74% -$2.91M 0.01% 193
2023
Q1 		$3.84M Sell
5,496,146
-71,078
-1% -$57.6K 0.03% 131
2022
Q4 		$4.57M Sell
5,567,224
-468,467
-8% -$462K 0.04% 132
2022
Q3 		$6.28M Buy
6,035,691
+478,309
+9% +$764K 0.04% 123
2022
Q2 		$10.3M Buy
5,557,382
+214,266
+4% +$445K 0.06% 113
2022
Q1 		$15.7M Buy
5,343,116
+16,989
+0.3% +$59.5K 0.07% 117
2021
Q4 		$25.5M Buy
5,326,127
+707,773
+15% +$4.57M 0.08% 125
2021
Q3 		$35M Buy
4,618,354
+139,808
+3% +$895K 0.08% 127
2021
Q2 		$33.4M Buy
4,478,546
+409,291
+10% +$3.15M 0.06% 148
2021
Q1 		$31.7M Buy
4,069,255
+1,526,864
+60% +$15.3M 0.06% 148
2020
Q4 		$23.5M Buy
2,542,391
+2,088,322
+460% +$18.2M 0.06% 131
2020
Q3 		$3.13M Buy
+454,069
New +$2.75M 0.02% 131

ARK Investment Management's SURF Position: Q3 2023 in Review

ARK Investment Management sold out of Surface Oncology, Inc. Common Stock (SURF) in Q3 2023, closing a stake of 1,412,077 shares — an estimated $1.23M sold.

ARK Investment Management first reported a position in SURF in Q3 2020 and held it in 12 quarters. The position peaked at $35M in Q3 2021. 0 funds tracked by Wall St. Rank hold SURF as of Q3 2023.

  • ARK Investment Management reported no remaining Surface Oncology, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • ARK Investment Management sold 1,412,077 Surface Oncology, Inc. Common Stock shares in Q3 2023, an estimated $1.23M.
  • ARK Investment Management first reported a position in Surface Oncology, Inc. Common Stock in Q3 2020 and held it in 12 quarters.
  • ARK Investment Management's Surface Oncology, Inc. Common Stock position peaked at $35M in Q3 2021.
  • 0 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q3 2023.

Based on ARK Investment Management's 13F filing for Q3 2023, filed 18 Oct 2023.